Canadian Consortium for the Investigation of Cannabinoids

What Canadian Consortium for the Investigation of Cannabinoids does

The Canadian Consortium for the Investigation of Cannabinoids (CCIC) is a federally registered Canadian nonprofit organization (corporation number 442869-2) founded in 2000 and incorporated in 2007, headquartered at a Vancouver mailing address. It operates as a national membership community of basic and clinical researchers, healthcare professionals, educators, and patient advocates promoting evidence-based education and research on the endocannabinoid system, the therapeutic applications of cannabinoids, the potential harms of cannabis use, and the health and societal impacts of non-medical cannabis use. Its product portfolio centers on the Canadian Cannabis Syllabus (a 9-module accredited online learning program offering up to 9 CME credits through the Royal College of Physicians and Surgeons of Canada), the annual Canadian Cannabis Research Summit co-hosted with the Toronto Cannabis and Cannabinoid Research Consortium (attracting 400+ participants for consecutive years), a quarterly virtual Cannabinoid Research Seminar Series, and a six-node national research network spanning British Columbia, Alberta, Prairie Territories, Southern Ontario, Ottawa/Quebec, and the Maritimes. The organization also operates the CCIC Neuroscience Fellowship ($10,000 award via Brain Canada) and Trainee Travel Awards ($500) to support trainee development.

The underlying technology is a web-based platform with a membership management system, an LMS for the Canadian Cannabis Syllabus, an event registration platform, and email marketing infrastructure, supported by third-party integrations with Stripe (payments), MailChimp (email), Flywheel (hosting), and Google Analytics (analytics). The business model is a multi-stream nonprofit revenue structure comprising annual membership subscriptions across five tiers ($25-$200 CAD), conference registration fees (with member discounts), online education course fees, and donations (including matched funds via Brain Canada). Membership serves as both a recurring revenue stream and a community-building mechanism, while the conference functions as the principal demand-generation event. Go-to-market is community-led and event-driven, leveraging academic and medical institution partnerships, board member affiliations with 10+ Canadian universities, and six regional node leads as primary recruitment channels.

Name

Canadian Consortium for the Investigation of Cannabinoids

Legal name

Canadian Consortium for the Investigation of Cannabinoids

Website

https://ccic.net

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

1–10 employees

Short description

CCIC is a federally registered Canadian nonprofit founded in 2000 that serves physicians, researchers, allied healthcare professionals, trainees, and patient advocates through evidence-based cannabis and cannabinoid research, accredited online education, an annual national research summit, and a six-node national research network.

Ownership category

akta.pro rank

Product category

Professional Medical Education

NAICS

Religious, Grantmaking, Civic, Professional, and Similar Organizations (813), Professional, Scientific, and Technical Services (541)

SIC

Services-Educational Services (8200), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

akta.pro secondary industries

Behavioral Health & Counseling (Social Work, Psychology, Substance Use CE) (EDAAALAD), Clinical Research Support (CRC/CTA) (EDAOAJAO)

Keywords

• Cannabinoid research education
• Medical cannabis training
• Healthcare professional membership
• Clinical cannabis seminars
• Evidence-based cannabis curriculum

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Membership Fees: Annual membership fees from multiple categories including Full Members (Physicians at $150 CAD, Researchers/Healthcare/Educators at $75 CAD), Associate Members (Industry at $200 CAD, Trainees at $25 CAD, Patients/Advocacy at $25 CAD). Membership fees are subject to a $7.50 processing fee and applicable taxes.
2. Conference Registration: Revenue from annual conference registration fees. Members receive discounted registration fees. The conference typically attracts over 400 participants.
3. Online Education (Canadian Cannabis Syllabus): The Canadian Cannabis Syllabus is a 9-module online learning program accredited by the Royal College of Physicians and Surgeons of Canada. Healthcare professionals may claim up to 9 hours of continuing medical education credits.
4. Donations: The CCIC accepts donations to support its mission. Unless otherwise specified, donations contribute to expanding trainee programs. A donation from M. Wayne and J. Coleman Family Fund was matched 1:1 by the Canada Brain Research Fund.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels10 records

Core offering

The CCIC is a federally registered Canadian nonprofit organization of basic and clinical researchers, healthcare professionals, and educators that promotes research and evidence-based education concerning the endocannabinoid system, therapeutic applications of cannabinoids, potential harms of cannabis use, and the health and societal impacts of non-medical cannabis use. It sells annual memberships, an accredited 9-module online CME program (Canadian Cannabis Syllabus), an annual national research conference (Canadian Cannabis Research Summit), quarterly virtual seminars, and trainee scholarships and fellowships.

Product overview

The CCIC operates as a federally registered Canadian nonprofit organization offering a portfolio of membership-based programs and educational services focused on cannabis and cannabinoid research and evidence-based education. The core offerings include the Canadian Cannabis Syllabus (a 9-module accredited online learning program for healthcare professionals), the annual Canadian Cannabis Research Summit conference, quarterly virtual Cannabinoid Research Seminar Series, and the national CCIC Research Network organized across 6 regional nodes. The CCIC supports trainee development through the Neuroscience Fellowship ($10,000 awards via Brain Canada partnership) and Trainee Travel Awards. Membership provides access to networking, educational resources, seminars, and conference discounts. The organization represents basic and clinical researchers, healthcare professionals and educators promoting balanced evidence-based perspectives on the endocannabinoid system, therapeutic applications of cannabinoids, and health impacts of cannabis use.

Differentiator

Problem solved

Functional benefit

Brands

• Canadian Cannabis Syllabus (CCS): A comprehensive, evidence-based online learning program focused on the use of cannabis and cannabinoids in clinical settings, developed by recognized experts in cannabinoid research.
• Canadian Cannabis Research Summit
• CCIC Cannabinoid Research Seminar Series

Products and services

• CCIC Membership

Quantifiable outcome

• Conference attendance exceeded 400 participants for consecutive years
• +3 more outcomes

Named customers12 records

Segments6 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• Health CanadacoreOthersHealth Canada is the Canadian government department responsible for national public health. CCIC maintains an affiliated relationship and references Health Canada's cannabis information resources. The Canada Brain Research Fund involves Health Canada in funding partnerships.
• Canadian Centre on Substance Use and Addiction (CCSA)coreStrategic or Co-development PartnerCCSA seeks to fill gaps in knowledge, provide practical resources and evidence-informed solutions to promote reduction of harms associated with substance use and addiction. CCIC promotes CCSA's cannabis research database and educational resources. Collaborates on Lower Risk Cannabis Use Guidelines.
• Michael G. DeGroote Centre for Medicinal Cannabis Research at McMaster UniversitycoreStrategic or Co-development PartnerMcMaster-based center focusing on curating evidence-based content, conducting cutting-edge research, and creating a network of medicinal cannabis professionals. Listed as affiliated organization on CCIC website.
• Toronto Cannabis and Cannabinoid Research Consortium (TC3)coreStrategic or Co-development PartnerTC3 is a network of researchers from University of Toronto and affiliated health services engaged in health research on cannabis and cannabinoids. CCIC co-hosts the annual Canadian Cannabis Research Summit with TC3.
• Cannabis Research Initiative of Saskatchewan (CRIS)coreStrategic or Co-development PartnerInterdisciplinary research team at University of Saskatchewan exploring application of cannabinoids and cannabis derivatives for health, disease and disorders in humans and animals. Listed as affiliated organization.
• International Cannabinoid Research Society (ICRS)coreStrategic or Co-development PartnerWorld's foremost research organization devoted to scientific cannabinoid research, hosting annual scientific conferences since 1990. CCIC promotes ICRS events and historical collaboration with founding members including Dr. Raphael Mechoulam.
• International Association for Cannabinoid Medicines (IACM)minorStrategic or Co-development PartnerAssociation that advances knowledge on cannabis, cannabinoids, the endocannabinoid system and related topics, especially regarding therapeutic potential. Listed as affiliated organization.
• MNP (Accounting Firm)minorImplementation/ SI/ Consulting PartnerThe Board of Directors has appointed MNP to audit the corporation's financial activities. MNP is a Canadian accounting and business advisory firm.
• Canadian Coalition for Seniors' Mental Health (CCSMH)minorStrategic or Co-development PartnerCCIC promotes CCSMH's free e-learning modules on Cannabis and Older Adults, accredited for physicians, nurse practitioners, pharmacists, and other healthcare providers. Each module individually accredited for up to 6.75 hours total.

Scale indicators3 records

Recent moves8 records

Expansion highlights6 records

Others

• Multidisciplinary Association for Psychedelic Studies (MAPS): Research and education non-profit advancing psychedelic and cannabinoid therapy through evidence generation and clinician training. Operates a comparable non-profit model combining accredited education, research funding, and policy engagement.

Direct peers

• Society of Cannabis Clinicians: U.S.-based professional society of clinicians focused on cannabis therapeutics. Comparable member-based clinician-education model with CME-style content delivery to healthcare practitioners.
• Toronto Cannabis and Cannabinoid Research Consortium (TC3): University of Toronto–affiliated network of cannabis and cannabinoid researchers that co-hosts the Canadian Cannabis Research Summit with CCIC. Highly comparable research-network structure and member base.
• International Association for Cannabinoid Medicines (IACM): Global association that advances knowledge on cannabis, cannabinoids, and the endocannabinoid system with a focus on therapeutic potential. Listed as an affiliated organization of CCIC and serves a directly comparable clinical-education mission.
• International Cannabinoid Research Society (ICRS): The world's foremost scientific organization devoted to cannabinoid research and host of annual scientific conferences since 1990. Direct international peer of CCIC, with which it has historical collaboration including founding-member ties to Dr. Raphael Mechoulam.
• Canadian Centre on Substance Use and Addiction (CCSA): Canadian non-profit providing evidence-informed resources on substance use including cannabis. Collaborates with CCIC on Lower Risk Cannabis Use Guidelines and shares a comparable national research-and-education mandate in Canada.

Regional players

• BC Centre on Substance Use: UBC-based research center focused on substance use including cannabis, co-located with CCIC's BC Node Lead (MJ Milloy). Comparable evidence-generation and clinician-education mission at the provincial level.
• Cannabis Research Initiative of Saskatchewan (CRIS): Interdisciplinary cannabis research team at the University of Saskatchewan listed as an affiliated CCIC organization. Operates within one Canadian region and provides a regional complement to CCIC's national scope.
• Michael G. DeGroote Centre for Medicinal Cannabis Research: McMaster University-based center curating evidence-based cannabis content and networks. Listed as an affiliated organization of CCIC and represents a comparable single-institution research hub within the broader CCIC ecosystem.

Broad incumbents

• Americans for Safe Access: Largest U.S. member-based organization promoting safe and legal access to cannabis for therapeutic use and research. Broader advocacy-and-education mandate versus CCIC's strictly evidence-based clinical-research focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cciceducation

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canadian Consortium for the Investigation of Cannabinoids